Medical equipment

Pre-Filled Saline Syringes Market, 2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 16, 2019
Medical Supplies, Health, Medical equipment, Drug paraphernalia, Medicine, Syringe, Saline, Health

The "Pre - Filled Saline Syringes Market to 2027 - Global Analysis and Forecasts by Type; End User, and Country" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pre - Filled Saline Syringes Market to 2027 - Global Analysis and Forecasts by Type; End User, and Country" report has been added to ResearchAndMarkets.com's offering.
  • The global pre-filled saline syringes market is expected to reach US$ 744.4 Mn in 2027 from US$ 402.5 Mn in 2018.
  • However, factors such as frequent product recall of pre-filled saline syringes are likely to pose a negative impact on market growth.
  • In 2018, the pre-filled saline syringes with 3 ml syringes segment held the largest market share of 46% of the pre-filled saline syringes market, by type.

India Air Purifiers Market Report 2019 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 16, 2019
Retail, Home Goods, Construction & Property, Building Systems, Building biology, Filters, Articles, Medical equipment, Eureka Forbes, Purifier, Air purifier, Technology, HEPA, Chemistry

In recent years, the air purifier market has witnessed a hike in demand fueled by degrading air quality and increasing concern toward health issues.

Key Points: 
  • In recent years, the air purifier market has witnessed a hike in demand fueled by degrading air quality and increasing concern toward health issues.
  • Moreover, the demand for air purifiers is no longer limited to residential and industrial uses; recently, the commercial market has also opened up to the air purifier industry.
  • High-efficiency particulate air (HEPA)-based air purifiers occupy almost 98.4% of total air purifier sales and this trend is expected to continue.
  • Some of the major players operating in India air purifier market are Philips India Ltd., Sharp Business Systems (India) Pvt Ltd., Blueair India Pvt Ltd., Eureka Forbes Ltd., Dyson Technology India Pvt Ltd., Honeywell India Pvt Ltd., LG Electronics India Pvt Ltd., Kent R O Systems Ltd., Atlanta Healthcare, Panasonic India Pvt Ltd., Crusaders Technologies India Pvt.

Global Surgical Lights Market 2019-2023 | Evolving Opportunities with Engineered Medical Solutions Company, LLC d/b/a/ BihlerMed and Herbert Waldmann GmbH & Co. KG | Technavio

Retrieved on: 
Wednesday, October 16, 2019
Medical devices, Health, Medical equipment, Surgery, Surgical lighting, Medical device, Marketplace

View the full release here: https://www.businesswire.com/news/home/20191016005486/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191016005486/en/
    Technavio has announced its latest market research report titled global surgical lights market 2019-2023.
  • In addition, the emergence of shadow-less surgical lights is expected to boost the growth of the surgical lights market.
  • The growing adoption of LED lights is encouraging vendors in the market to introduce a wide range of energy-efficient surgical lights.
  • Major Five Surgical Lights Companies:
    Engineered Medical Solutions Company, LLC d/b/a/ BihlerMed owns and operates businesses in the medical devices and accessories segment.

Omega Medical Imaging First in the World to Receive FDA Clearance on Artificial Intelligence Imaging System That Reduces Dose

Retrieved on: 
Tuesday, October 15, 2019
Medical physics, Fluoroscopy, Medicine, Medical imaging, Applied sciences, Medical equipment, Health

The unique FluoroShield system allows for auto collimation during interventional fluoro or cine cases while maintaining a perspective of surrounding anatomy.

Key Points: 
  • The unique FluoroShield system allows for auto collimation during interventional fluoro or cine cases while maintaining a perspective of surrounding anatomy.
  • Brian Fleming, President of Omega Medical Imaging states, "Until now products on the market have only been able to manage radiation to patients and staff.
  • Omega Medical Imaging LLC based in Sanford Florida USA is an innovator in the design, manufacture, delivery, and support of Artificial Intelligence Fluoroscopy/Cine (AIF/C) Imaging systems for hospitals and healthcare facilities around the globe.
  • To request further information about Omega Medical Imaging, please visit its website at https://www.omegamedicalimaging.com .

Gathering Clinical Evidence for Medical Device Studies: Two Day Course - London, United Kingdom - May 11-12, 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 15, 2019
Medical devices, Health, Medical equipment, Design of experiments, Global Harmonization Task Force, Medical statistics, Articles, Medical device, Health, Clinical study design, Pharmaceutical industry, Knowledge

Standards and guidelines applicable to medical device clinical evidence, ISO, GHTF (IMDRF), MEDDEV and NBMED

Key Points: 
  • Standards and guidelines applicable to medical device clinical evidence, ISO, GHTF (IMDRF), MEDDEV and NBMED
    What documents are required - how is clinical data used?
  • What types of studies and study designs are applicable to pre-market studies?
  • This presentation will include template documentation for clinical investigation plans, investigator brochures, case report forms and consent forms
    Practical considerations for final study reports, publications and presentations of study results
    View source version on businesswire.com: https://www.businesswire.com/news/home/20191015005540/en/

Gathering and Using Clinical Evidence for CE Marking and Post-Market Compliance in Line with the New MDR (London, United Kingdom - November 9-10, 2020) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 15, 2019
Health, Clinical trials, Medical equipment, Design of experiments, Global Harmonization Task Force, Medical statistics, Articles, Medical device, Health, Clinical study design, Pharmaceutical industry, Knowledge

Standards and guidelines applicable to medical device clinical evidence, ISO, GHTF (IMDRF), MEDDEV and NBMED

Key Points: 
  • Standards and guidelines applicable to medical device clinical evidence, ISO, GHTF (IMDRF), MEDDEV and NBMED
    What documents are required - how is clinical data used?
  • What types of studies and study designs are applicable to pre-market studies?
  • This presentation will include template documentation for clinical investigation plans, investigator brochures, case report forms and consent forms
    Practical considerations for final study reports, publications and presentations of study results
    View source version on businesswire.com: https://www.businesswire.com/news/home/20191015005535/en/

RMS Medical Products to Commence Trading on NASDAQ

Retrieved on: 
Monday, October 14, 2019
General Health, Health, Medical devices, Drug paraphernalia, Medical equipment, Syringe, OTC Markets Group, Medicine, Technology, Health sciences

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (RMS Medical or the Company) today announced that its common stock has been approved for listing and is expected to begin trading on the NASDAQ Capital Market on October 17, 2019 under the current symbol REPR.

Key Points: 
  • Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (RMS Medical or the Company) today announced that its common stock has been approved for listing and is expected to begin trading on the NASDAQ Capital Market on October 17, 2019 under the current symbol REPR.
  • "This NASDAQ listing is a significant milestone and a reflection of our growth and evolution as a publicly traded company, said Don Pettigrew, President and CEO.
  • RMS Medical Products develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world.
  • The FREEDOM Syringe Infusion System currently includes the FREEDOM60 and FreedomEdge Syringe Infusion Drivers, RMS Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Safety Needle Sets.

Analytical Report for Healthcare Licensing with Focus on Medical Imaging - ResearchAndMarkets.com

Retrieved on: 
Monday, October 14, 2019
Professional services, Consulting, Medical physics, Medical imaging, Image processing, Nuclear medicine, Medicine, Applied sciences, Academic disciplines, Medical equipment

The "Analytical Report for Healthcare Licensing with Focus on Medical Imaging" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Analytical Report for Healthcare Licensing with Focus on Medical Imaging" report has been added to ResearchAndMarkets.com's offering.
  • Medical imaging encompasses different imaging modalities and processes to image the human body for diagnostic and treatment purposes and therefore plays an important role in initiatives to improve public health for all population groups.
  • An in-depth update on its licensing is studied in this report.
  • 80+ licensing news with a focus on Medical Imaging, during January 1, 2018, to August 31, 2019, are reported and analyzed to provide a snapshot view of the current business trends.

Croma-Pharma Reveals New Packaging Design for the Arthrex ACP® Double Syringe System

Retrieved on: 
Monday, October 14, 2019
Medical equipment, Drug paraphernalia, Syringe, Automatic Colt Pistol, Technology

In the course of the portfolio alignment Croma proudly introduces its own branded packaging design for the Arthrex ACP double syringe system.

Key Points: 
  • In the course of the portfolio alignment Croma proudly introduces its own branded packaging design for the Arthrex ACP double syringe system.
  • The Arthrex ACP double syringe system for aesthetic applications is exclusively distributed in 9 European countries by Croma.
  • The Arthrex ACP double syringe system builds the basis of the Arthrex personalized cell therapy.
  • With products such as the Arthrex ACP double syringe, Arthrex is one of the world's leading companies in the field of biotechnology, since 1981.

Shareholder Alert: Robbins Arroyo LLP Reminds Investors Inogen, Inc. (INGN) Sued for Misleading Shareholders

Retrieved on: 
Friday, October 11, 2019
Legal, Professional services, Medicine, Industrial gases, Oxygen, Chemistry, Clinical medicine, Medical equipment, Oxygen concentrator, Oxygen therapy, NASDAQ, salesforce.com, Securities Exchange Act

Shareholder rights law firm Robbins Arroyo LLP reminds investors that shareholders of Inogen (NASDAQ: INGN) filed a class action complaint against the company for alleged violations of the Securities Exchange Act of 1934 between November 8, 2017 and February 26, 2019.

Key Points: 
  • Shareholder rights law firm Robbins Arroyo LLP reminds investors that shareholders of Inogen (NASDAQ: INGN) filed a class action complaint against the company for alleged violations of the Securities Exchange Act of 1934 between November 8, 2017 and February 26, 2019.
  • Inogen is a medical technology company that primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients.
  • If you suffered a loss as a result of Inogen's misconduct, click here .
  • Inogen subsequently increased its FY18 guidance range, emphasizing that the company's strong direct-to-customer sales were the result of the strong sales acumen of its salesforce.